Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-025035
Filing Date
2020-09-14
Accepted
2020-09-14 20:02:14
Documents
1
Period of Report
2020-09-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3874
  Complete submission text file 0000899243-20-025035.txt   5365
Mailing Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142 617-500-8099
Compass Therapeutics, Inc. (Issuer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address
Kaplan Brett (Reporting) CIK: 0001778763 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55939 | Film No.: 201174425